Dan
Stamer

W. Daniel Stamer, Ph.D., is an expert in the pathobiology of ocular hypertension and glaucoma drug development. Prof. Stamer currently serves as the Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology at Duke University. The primary research focus of the Stamer laboratory is to understand the molecular and cellular mechanisms that regulate aqueous humor outflow such that novel targets can be identified and exploited therapeutically to lower intraocular pressure in people with glaucoma. Over the past 30+ years, Prof. Stamer has pioneered the development of cellular, tissue, organ culture and murine model systems for use by his laboratory and others to study conventional outflow physiology and pharmacology. His laboratory has worked closely with industry, assisting 60+ biotechnology companies in the development/pre-clinical testing of new classes of glaucoma drugs that target the diseased conventional outflow pathway responsible for ocular hypertension. Research progress is documented in 200 peer-reviewed manuscripts, 34 refereed review articles/white papers, 8 book chapters and 23 editorials, together having over 13,000 citations. His work was recognized by the Rudin Prize for Glaucoma in 2012 and the Research to Prevent Blindness Foundation in 2013. Prof. Stamer was elected as ARVO trustee in 2015 and ARVO president in 2020. In 2022, he was elected to the Glaucoma Research Society, restricted to the top 100 glaucoma scientists worldwide.